Status:
RECRUITING
Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Avicanna Inc
Conditions:
Pain
Sleep
Eligibility:
All Genders
19+ years
Brief Summary
This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, vali...
Detailed Description
Given the recent legislative changes, medical cannabis has quickly garnered attention in clinical research as a potential pharmacotherapy to treat epilepsy, mood disorders, anxiety/depression disorder...
Eligibility Criteria
Inclusion
- Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent
- Primary therapeutic indications for MC use: pain, epilepsy, sleep, and/or anxiety/depression.
- Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study
Exclusion
- Concomitant use of illicit drugs
- Concomitant use of recreational cannabis
Key Trial Info
Start Date :
July 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04526093
Start Date
July 15 2020
End Date
July 1 2027
Last Update
July 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital, UHN
Toronto, Ontario, Canada, M5G 2C4